Annual D&A
N/A
December 1, 2023
Summary
- CYTO annual depreciation & amortization is not available.
Performance
CYTO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
June 1, 2024
Summary
- CYTO quarterly depreciation & amortization is not available.
Performance
CYTO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
June 1, 2024
Summary
- CYTO TTM depreciation & amortization is not available.
Performance
CYTO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
CYTO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CYTO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Altamira Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $128.20 K(+53.5%) | - | - |
| Dec 2021 | $83.50 K(+264.6%) | - | - |
| Dec 2020 | $22.90 K(-28.0%) | - | - |
| Dec 2019 | $31.80 K(-57.0%) | - | - |
| Dec 2018 | $73.90 K(-41.3%) | $11.00 K(-32.9%) | $73.80 K(-18.3%) |
| Sep 2018 | - | $16.40 K(-24.8%) | $90.30 K(-13.5%) |
| Jun 2018 | - | $21.80 K(-11.4%) | $104.40 K(-11.2%) |
| Mar 2018 | - | $24.60 K(-10.5%) | $117.60 K(-6.6%) |
| Dec 2017 | $126.00 K(+31.5%) | $27.50 K(-9.8%) | $125.90 K(+5.3%) |
| Sep 2017 | - | $30.50 K(-12.9%) | $119.60 K(+4.9%) |
| Jun 2017 | - | $35.00 K(+6.4%) | $114.00 K(+10.3%) |
| Mar 2017 | - | $32.90 K(+55.2%) | $103.40 K(+7.8%) |
| Dec 2016 | $95.80 K | $21.20 K(-14.9%) | $95.90 K(-2.4%) |
| Sep 2016 | - | $24.90 K(+2.0%) | $98.30 K(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $24.40 K(-3.9%) | $95.50 K(-2.0%) |
| Mar 2016 | - | $25.40 K(+7.6%) | $97.40 K(+3.8%) |
| Dec 2015 | $93.90 K(+25.5%) | $23.60 K(+6.8%) | $93.80 K(+5.4%) |
| Sep 2015 | - | $22.10 K(-16.0%) | $89.00 K(+5.0%) |
| Jun 2015 | - | $26.30 K(+20.6%) | $84.80 K(+6.1%) |
| Mar 2015 | - | $21.80 K(+16.0%) | $79.90 K(+6.7%) |
| Dec 2014 | $74.80 K(+76.8%) | $18.80 K(+5.0%) | $74.90 K(+4.9%) |
| Sep 2014 | - | $17.90 K(-16.4%) | $71.40 K(+8.0%) |
| Jun 2014 | - | $21.40 K(+27.4%) | $66.10 K(+27.6%) |
| Mar 2014 | - | $16.80 K(+9.8%) | $51.80 K(+22.7%) |
| Dec 2013 | $42.30 K(+318.8%) | $15.30 K(+21.4%) | $42.20 K(+56.9%) |
| Sep 2013 | - | $12.60 K(+77.5%) | $26.90 K(+88.1%) |
| Jun 2013 | - | $7100.00(-1.4%) | $14.30 K(+98.6%) |
| Mar 2013 | - | $7200.00 | $7200.00 |
| Dec 2012 | $10.10 K | - | - |
FAQ
- What is the all time high annual D&A for Altamira Therapeutics?
- What is the all time high quarterly D&A for Altamira Therapeutics?
- What is the all time high TTM D&A for Altamira Therapeutics?
What is the all time high annual D&A for Altamira Therapeutics?
Altamira Therapeutics all-time high annual depreciation & amortization is $128.20 K
What is the all time high quarterly D&A for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly depreciation & amortization is $35.00 K
What is the all time high TTM D&A for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM depreciation & amortization is $125.90 K